Johnson & Johnson ( JNJ) - Key Metrics
JNJ Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $10.11 | $2.11 | ? | ? |
| 2025Q4 | $10.11 | $2.11 | $3.01 | $2.25 |
| 2025Q3 | $9.88 | $2.12 | ? | ? |
| 2025Q3 | $9.88 | $2.12 | $3.78 | $3.45 |
JNJ Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 61.71% | 24.56 |
| 2025Q4 | 61.20% | 24.63 |
| 2025Q3 | 61.28% | 21.85 |
| 2025Q3 | 60.79% | 21.40 |
JNJ Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 0.63% |
| 2025Q4 | 1.09% | 0.62% |
| 2025Q3 | ? | 0.70% |
| 2025Q3 | 1.90% | 0.71% |
JNJ
List: Champions
Price: $228.12
Dividend Yield: 2.32%
Forward Dividend Yield: 2.40%
Payout Ratio: 75.04%
Dividend Per Share: 5.36 USD
Earnings Per Share: 11.03 USD
P/E Ratio: 20.91
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 6.9 million
Ebitda: 2.9 billionMarket Capitalization: 539.6 billion
Average Dividend Frequency: 4
Years Paying Dividends: 26
DGR3: 5.22%
DGR5: 5.40%
DGR10: 5.83%
DGR20: 7.52%